%PDF-1.7
%
1 0 obj
<>stream
Generalization and Representativeness of Phase III Immune Checkpoint Blockade Trials in Non-Small Cell Lung Cancer: Strict Trial Eligibility in Lung Cancer
Acrobat Distiller 7.0 (Windows); modified using iText 4.2.0 by 1T3XT2020-04-22T16:04:30-07:00
endstream
endobj
4 0 obj
<>stream
HWێE7<; g7lđDf2!ޜSMj.VÀ쮮:u}4gg/gY,7ўb0r,%}I|rY]/| j_M~YM5rgFU}eڶ^˴jvaC=nj!;r#_Ҝ]ﺾ֕yی#ZnZ0al:YVúmU.8NNHl6
L}SqՎÈF3j(krW+`e{E:I%ׇJ] ^
/dCSk++:껛8iՇMcW...#ɆU|i)/Ą'g0?_v5D:}%$V DXX[ĥFjߦsnPL96tzEo}{jvkFCkJW%tlc m(^ yM墚 x|Τ=Fn%3Ll6>jòo22+CqV̙<6d%y@}ZgHaf 9.z~*$R>#/þj䃏_
TR|}%PL֚<pJBǹmR@)RK D1Uх%7L Scgecֻe
B0a
-ggu1fh"wicn+q䱺y
cb
_vʭ}s3Ֆ#UƩ\a:/^Ң ju酧 s.d+B8);RR?+p.=s}&7ǁZmkI=ιp9N.n!pL9nzxK8^>j91snťZv}%{w,PoZÈpOׇAkJJ)IWx[3d$mMI 5;,`Ki }㙉mKT9y
âN*]R3zXɫnAA
O>AG璱K)ShDǾZ+6S~sELw,du,
09'!YHgcqϓAR'YO5#'@+ A-ȁ(FØHi]^Zt,.V8#TDW"1MbHbFz
iTM"xi$K;QLkHSx/tK217ȣ.53ofL_;kL,\vspzc;Tآ[&ךXǓ)zmDmfI9a7H˲EKg.i+-醮q7vmf'>3Y0L3bj`'Fr
Dv
ZSvۜ~qc?diJSIF][5/wG=5n!MҬEMX+:
kin<=ѱo/41OCv!dR$ziESاI=7{UMaw~+}3'wOW@'ȡ˝rV,ܼK_@y>]=~H^KaԸiqluz$bh;8LݎRvᰗ|#j
/>]nИv')0'"sKׯxZ~\f9~G{.I$4;HIT,=9K6Y'-&Y(ho^$y
xmN!,նMS2GWWz$VSeCaS.b(tP86 :Ʋ+MLyPHO?ϗ?,r->9q6\"" l"Uo^%A@zkNjNDwЉօ3nJ_FbE==%Y<-ZWhh3;ZlR^ M)nU(H&Yo.uv/%&NzbV
#Io ?;ua#EmUc2^5mXxВ='RI dek4gҦɆh3ȼü^u
M~bb$ yY0˾xZKR]w'ML=(wUʎ2Ƞ}۟?ǿOQAхY£7O]k/3q˛$ӚWB*@s/BɯYhq:U%/XCvcC\ty[Ty$Hq_"56HG<( Ӯr4-n90>\c`$1"TAI=&P%=P/ʥ3ӅJ*N@ f"hF%CM:\uBKKOKJ㡨KꡑMUdu[`
d3b1i8=a<9~xRa7xj~A"SQF"즨=}RG SD7S!%6D1V$6D"hcch~x,VܯU!]$@FrF}^ԏWspGWQ>Jђ"y
dc?Bw+w:_PĉO<Х'fh<
ٜz=,"q+zR%@,ĹיZ kdzp0q)ѠD AEj֡,A(q cg<&ͮ8b&fD
vbLz!G}"hƤOO-0k焏W Yn\KZ>YiZS |A,~87xʰycW,H]V,Hz
&|N /&&k&w